Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial.
Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. Jamaati H, et al. Among authors: haseli s. Eur J Pharmacol. 2021 Apr 15;897:173947. doi: 10.1016/j.ejphar.2021.173947. Epub 2021 Feb 16. Eur J Pharmacol. 2021. PMID: 33607104 Free PMC article. Clinical Trial.
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial.
Barati S, MohammadReza Hashemian S, Tabarsi P, Abedini A, Ashrafzadeh M, Haseli S, Abtahian Z, Yousefian S, Dastan A, Sobhanian A, Dastan F. Barati S, et al. Among authors: haseli s. Int Immunopharmacol. 2021 Oct;99:108043. doi: 10.1016/j.intimp.2021.108043. Epub 2021 Aug 4. Int Immunopharmacol. 2021. PMID: 34426105 Free PMC article. Clinical Trial.
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Dastan F, et al. Among authors: haseli s. Int Immunopharmacol. 2020 Nov;88:106869. doi: 10.1016/j.intimp.2020.106869. Epub 2020 Aug 4. Int Immunopharmacol. 2020. PMID: 32889241 Free PMC article. Clinical Trial.
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
Tabarsi P, Barati S, Jamaati H, Haseli S, Marjani M, Moniri A, Abtahian Z, Dastan A, Yousefian S, Eskandari R, Saffaei A, Monjazebi F, Vahedi A, Dastan F. Tabarsi P, et al. Among authors: haseli s. Int Immunopharmacol. 2021 Jan;90:107205. doi: 10.1016/j.intimp.2020.107205. Epub 2020 Nov 13. Int Immunopharmacol. 2021. PMID: 33214093 Free PMC article. Clinical Trial.
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form.
Tabarsi P, Vahidi H, Saffaei A, Hashemian SMR, Jammati H, Daraei B, Mahboubi A, Kobarfard F, Marjani M, Moniri A, Abtahian Z, Abedini A, Eslaminejad A, Heshmatnia J, Mirenayat MS, Fakharian A, Seifi S, Sadeghi M, Dastan A, Haseli S, Nadji SA, Eskandari R, Yousefian S, Varahram M, Zali A, Velayati AA, Dastan F. Tabarsi P, et al. Among authors: haseli s. Iran J Pharm Res. 2021 Fall;20(4):1-8. doi: 10.22037/ijpr.2021.115510.15401. Iran J Pharm Res. 2021. PMID: 35194422 Free PMC article.
Paranasal sinuses computed tomography findings in anosmia of COVID-19.
Naeini AS, Karimi-Galougahi M, Raad N, Ghorbani J, Taraghi A, Haseli S, Mehrparvar G, Bakhshayeshkaram M. Naeini AS, et al. Among authors: haseli s. Am J Otolaryngol. 2020 Nov-Dec;41(6):102636. doi: 10.1016/j.amjoto.2020.102636. Epub 2020 Jul 3. Am J Otolaryngol. 2020. PMID: 32652405 Free PMC article.
82 results